BIO Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . BIO Key International
BKYI Stock  USD 1.03  0.17  14.17%   
BIO Key financial statements provide useful quarterly and yearly information to potential BIO Key International investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BIO Key financial statements helps investors assess BIO Key's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BIO Key's valuation are summarized below:
Gross Profit
3.4 M
Profit Margin
(0.92)
Market Capitalization
3.3 M
Enterprise Value Revenue
0.7034
Revenue
7 M
We have found one hundred twenty available fundamental signals for BIO Key International, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of BIO Key International prevailing fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 5.2 M. Enterprise Value is estimated to decrease to about 4.7 M

BIO Key Total Revenue

4.98 Million

Check BIO Key financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIO Key's main balance sheet or income statement drivers, such as Depreciation And Amortization of 573.1 K, Interest Expense of 186.6 K or Selling General Administrative of 5.1 M, as well as many indicators such as Price To Sales Ratio of 0.24, Dividend Yield of 0.0028 or PTB Ratio of 1.49. BIO financial statements analysis is a perfect complement when working with BIO Key Valuation or Volatility modules.
  
Check out the analysis of BIO Key Correlation against competitors.

BIO Key Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10 M5.2 M9.2 M
Slightly volatile
Short and Long Term Debt Total312.4 K328.8 K1.6 M
Pretty Stable
Other Current Liabilities963.2 K1 M647.5 K
Slightly volatile
Total Current Liabilities3.1 M2.9 M2.4 M
Slightly volatile
Property Plant And Equipment Net226.5 K295.6 K215.5 K
Slightly volatile
Accounts Payable1.6 M1.5 M778.1 K
Slightly volatile
Cash558.7 K588.1 K2.4 M
Pretty Stable
Non Current Assets Total2.1 M2.2 M3.4 M
Pretty Stable
Non Currrent Assets Other251.1 K264.3 K4.2 M
Slightly volatile
Cash And Short Term Investments558.7 K588.1 K2.5 M
Pretty Stable
Common Stock Total Equity6697044.6 K
Slightly volatile
Common Stock Shares Outstanding391 K644.3 K529 K
Pretty Stable
Liabilities And Stockholders Equity10 M5.2 M9.2 M
Slightly volatile
Inventory657.9 K512.6 K940.7 K
Slightly volatile
Other Current Assets800.8 K418.8 K845.2 K
Very volatile
Other Stockholder Equity152.2 M145 M88.4 M
Slightly volatile
Total Liabilities4.7 M3.1 M2.6 M
Slightly volatile
Property Plant And Equipment Gross1.6 M1.6 M452.1 K
Slightly volatile
Total Current Assets5 M3 M5.6 M
Slightly volatile
Short Term Debt151 K158.9 K540.1 K
Pretty Stable
Common Stock88.0792.74.9 K
Slightly volatile
Net Receivables1.6 M1.5 M1.3 M
Slightly volatile
Other Assets0.860.9258.2 K
Pretty Stable
Property Plant Equipment240.4 K371.8 K225.8 K
Slightly volatile
Current Deferred Revenue354.8 K373.5 K431.5 K
Pretty Stable
Other Liabilities57.5 K60.6 K156.6 K
Slightly volatile
Intangible Assets1.2 M1.3 M3.7 M
Slightly volatile
Capital Surpluse88.3 M137.8 M87.2 M
Slightly volatile
Non Current Liabilities Other345.7 K355.5 K328.3 K
Slightly volatile
Capital Stock88.0792.71 K
Slightly volatile
Capital Lease Obligations32.3 K34 K417.2 K
Slightly volatile
Short and Long Term Debt118.6 K124.9 K1.7 M
Slightly volatile

BIO Key Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization573.1 K531.1 K419.5 K
Slightly volatile
Interest Expense186.6 K196.4 K426.9 K
Pretty Stable
Selling General Administrative5.1 M9.7 M5 M
Slightly volatile
Total Revenue5 M8.9 M4.4 M
Slightly volatile
Other Operating Expenses20 M19.1 M9.8 M
Slightly volatile
Research Development2.3 M2.8 M1.7 M
Slightly volatile
Cost Of Revenue7.6 M7.3 M2.7 M
Slightly volatile
Total Operating Expenses7.5 M11.8 M6.8 M
Slightly volatile
Extraordinary Items240 K270 K294.4 K
Slightly volatile
Interest Income5.1 K5.4 K63.6 K
Slightly volatile
Selling And Marketing Expenses1.8 M2 M2.2 M
Slightly volatile
Preferred Stock And Other Adjustments628.7 K692.2 K770.2 K
Slightly volatile
Reconciled Depreciation712.4 K496.4 K1.2 M
Slightly volatile

BIO Key Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow2 M3 M2.7 M
Slightly volatile
Depreciation624.1 K531.1 K485.5 K
Slightly volatile
End Period Cash Flow558.7 K588.1 K2.4 M
Pretty Stable
Stock Based Compensation460.6 K305.6 K450.1 K
Pretty Stable
Change To Netincome791.8 K833.4 K1.1 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.240.25682
Slightly volatile
Dividend Yield0.00280.00270.0025
Slightly volatile
Average Payables565.2 K1.1 M704.4 K
Slightly volatile
Stock Based Compensation To Revenue0.02930.03080.1058
Pretty Stable
Capex To Depreciation0.00190.00190.6488
Slightly volatile
EV To Sales0.220.23682
Slightly volatile
Inventory Turnover15.516.3125.6781
Slightly volatile
Days Of Inventory On Hand28.1129.59334
Pretty Stable
Payables Turnover4.544.323.3998
Slightly volatile
Sales General And Administrative To Revenue0.671.190.9097
Slightly volatile
Average Inventory2.5 M2.4 M1.5 M
Slightly volatile
Research And Ddevelopement To Revenue0.340.361.1454
Slightly volatile
Capex To Revenue1.0E-41.0E-40.1015
Slightly volatile
Cash Per Share1.01.057.2364
Pretty Stable
Days Payables Outstanding82.9987.36494
Slightly volatile
Income Quality0.380.42.3718
Slightly volatile
Intangibles To Total Assets0.370.360.2929
Very volatile
Current Ratio0.70.732.5407
Pretty Stable
Capex Per Share0.0020.00210.1684
Slightly volatile
Average Receivables487.5 K513.2 K1.4 M
Slightly volatile
Revenue Per Share16.1615.929.9238
Slightly volatile
Interest Debt Per Share1.141.24.8847
Pretty Stable
Debt To Assets0.08840.0930.6155
Slightly volatile
Graham Number36.1732.9229.8991
Very volatile
Operating Cycle95.0100.0426
Pretty Stable
Days Of Payables Outstanding82.9987.36494
Slightly volatile
Ebt Per Ebit0.930.8882.557
Slightly volatile
Quick Ratio0.580.612.1682
Pretty Stable
Net Income Per E B T0.580.890.9196
Pretty Stable
Cash Ratio0.140.15911.1912
Pretty Stable
Days Of Inventory Outstanding28.1129.59334
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.121.151.0464
Very volatile
Fixed Asset Turnover31.1727.1537.7366
Slightly volatile
Debt Ratio0.08840.0930.6155
Slightly volatile
Price Sales Ratio0.240.25682
Slightly volatile
Asset Turnover1.621.551.1076
Pretty Stable

BIO Key Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.2 M5.5 M75.5 M
Slightly volatile
Enterprise Value4.7 M5 M71.6 M
Slightly volatile

BIO Fundamental Market Drivers

Cash And Short Term Investments511.4 K

BIO Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About BIO Key Financial Statements

Investors use fundamental indicators, such as BIO Key's revenue or net income, to determine how well the company is positioned to perform in the future. Although BIO Key's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue373.5 K354.8 K
Total Revenue8.9 M5 M
Cost Of Revenue7.3 M7.6 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 1.19  0.67 
Research And Ddevelopement To Revenue 0.36  0.34 
Revenue Per Share 15.92  16.16 
Ebit Per Revenue(1.02)(1.08)

Currently Active Assets on Macroaxis

VVisa Class A
CRMSalesforce
CRMSalesforce
MSFTMicrosoft
VVisa Class A
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
How To Invest In BIO
Details
Is BIO Stock a good investment?
Details
What is BIO Key's Net Worth?
Details
Largest Systems Software Companies
View
Largest Security & Protection Services Companies
View
Check out the analysis of BIO Key Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.66)
Revenue Per Share
6.323
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.56)
Return On Equity
(4.58)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY